Liquid injectable botulinum toxin type A (Eirion Therapeutics)

液体注射型A型肉毒毒素（Eirion Therapeutics）

Report date: 2025/12/04 20:00:08

Base Information

Drug NameLiquid injectable botulinum toxin type A (Eirion Therapeutics)
Drug Alias NameInjectable A1-09AI-09A1-09
ClassificationBiologics > Protein drugs > ToxinNatural product/Extract > Microbial extract
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsGlabellar lines
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEirion Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEirion Therapeutics IncShanghai Haohai Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsGlabellar lines
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A